Abstract
The development of antiviral drug resistance is an important problem in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Potent antiretroviral therapy (ART) is currently used for treatment, and typically consists of at least two reverse transcriptase (RT) inhibitors. To assess the impact of combination therapy on HIV-1 mutagenesis, the mutagenic outcome of combined drug treatment was determined with several different RT drug combinations. Significant increases in HIV-1 mutant frequencies were observed with combinations of nucleoside RT inhibitors as well as in combinations where nucleoside inhibitors were used along with hydroxyurea, a drug known to deplete nucleotide pools in cells. This indicates that combinations of RT drugs can act together to further increase HIV-1 mutant frequencies, which could have important implications for virus population dynamics and could compromise drug therapy regimens.
Original language | English (US) |
---|---|
Pages (from-to) | 116-121 |
Number of pages | 6 |
Journal | Virology |
Volume | 307 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1 2003 |
Externally published | Yes |
Bibliographical note
Funding Information:I thank L. Gajary for technical assistance and D. Pearl for helpful discussions. This research was supported by Public Health Service Grant GM56615.
Keywords
- Drug
- Evolution
- Mutagenesis
- Nucleoside
- Polymerase